Table: Daito -2020/21 group results

Daito Pharmaceutical

14/07/2021 07:00

Jul 14 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                   Year ended      Year ended       Year to       NEXT   
                May 31, 2021    May 31, 2020   May 31, 2022     YEAR     
                   LATEST         YEAR-AGO        COMPANY      COMPANY   
                   RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales             48.71           44.99          42.50                 
                 (+8.3 pct)      (+9.4 pct)     (+6.2 pct)               
  Operating          5.91            5.36           5.90                 
                 (+10.3 pct)     (+17.8 pct)    (-0.1 pct)               
  Recurring          6.07            5.46           6.00                 
                 (+11.1 pct)     (+17.7 pct)    (-1.1 pct)               
  Net
  Net                4.25            3.94           4.25                 
                 (+7.6 pct)      (+12.3 pct)    (+0.1 pct)               
  EPS            311.02 yen      309.66 yen     309.91 yen               
  EPS Diluted                    307.44 yen                              
  Ann Div         46.00 yen       46.00 yen      50.00 yen               
  -Q2 Div         23.00 yen       20.00 yen      25.00 yen               
  -Q4 Div         23.00 yen       26.00 yen      25.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T